PriceTargets.com logo

SeaStar Medical - ICU Stock Price Target and Predictions

  • Consensus Rating: Sell
  • Consensus Price Target: $6.00
  • Forecasted Upside: 61.73%
  • Number of Analysts: 1
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$3.71 As of 04/10/2026 05:00 PM ET
▼ -0.35 (-8.62%)

This chart shows the closing price for ICU by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New SeaStar Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ICU and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ICU

Analyst Price Target is $6.00
▲ +61.73% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for SeaStar Medical in the last 3 months. The average price target is $6.00, with a high forecast of $6.00 and a low forecast of $6.00. The average price target represents a 61.73% upside from the last price of $3.71.

This chart shows the closing price for ICU for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Sell

The current consensus among 1 investment analysts is to sell stock in SeaStar Medical. This rating has held steady since April 2024, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/17/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/15/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/15/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/14/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
10/12/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
1/10/2026
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
3/11/2026
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
4/10/2026

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/12/2026Maxim GroupSet Target$6.00
1/22/2026Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
10/8/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
9/27/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
4/20/2023Maxim GroupInitiated CoverageBuy$1,250.00
(Data available from 4/10/2021 forward)

News Sentiment Rating

0.75 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/12/2025
  • 2 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/12/2025
  • 1 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/11/2025
  • 3 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/11/2025
  • 1 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/10/2026
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/9/2026
  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/11/2026
  • 3 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/10/2026

Current Sentiment

  • 3 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

SeaStar Medical logo
SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.
Read More

Today's Range

Now: $3.71
Low: $3.60
High: $4.06

50 Day Range

MA: $2.79
Low: $2.21
High: $4.58

52 Week Range

Now: $3.71
Low: $2.07
High: $13.50

Volume

164,748 shs

Average Volume

258,795 shs

Market Capitalization

$14.80 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of SeaStar Medical?

The following Wall Street sell-side analysts have issued stock ratings on SeaStar Medical in the last twelve months: Maxim Group, Wall Street Zen, and Weiss Ratings.
View the latest analyst ratings for ICU.

What is the current price target for SeaStar Medical?

0 Wall Street analysts have set twelve-month price targets for SeaStar Medical in the last year. Their average twelve-month price target is $6.00, suggesting a possible upside of 61.7%. Maxim Group has the highest price target set, predicting ICU will reach $6.00 in the next twelve months. Maxim Group has the lowest price target set, forecasting a price of $6.00 for SeaStar Medical in the next year.
View the latest price targets for ICU.

What is the current consensus analyst rating for SeaStar Medical?

SeaStar Medical currently has 1 sell rating from Wall Street analysts. The stock has a consensus analyst rating of "Sell." A "sell" rating indicates that analysts believe ICU will underperform the market and that investors should sell shares of SeaStar Medical.
View the latest ratings for ICU.

What other companies compete with SeaStar Medical?

Other companies that are similar to SeaStar Medical include InspireMD, electroCore, Pulmonx, Envoy Medical and Spectral AI. Learn More about companies similar to SeaStar Medical.

How do I contact SeaStar Medical's investor relations team?

SeaStar Medical's physical mailing address is 1200 West Platt Street Suite 100, TAMPA FL, 33602. The company's listed phone number is 844-427-8100 and its investor relations email address is [email protected]. The official website for SeaStar Medical is seastarmedical.com. Learn More about contacing SeaStar Medical investor relations.